Literature DB >> 8927396

Radiation therapy for sinus malignancies.

J T Parsons1, F C Kimsey, W M Mendenhall, R R Million, N J Cassisi, S P Stringer.   

Abstract

Primary tumors arising in the nasal cavity and paranasal sinuses usually are considered together. Except in the nasal cavity, where occasional lesions present early because of nasal obstruction, most lesions are advanced at presentation, and the exact site of origin may be uncertain. Radiation therapy may be used alone or in combination with surgery in the management of patients with squamous cell carcinoma of these sites.

Entities:  

Mesh:

Year:  1995        PMID: 8927396

Source DB:  PubMed          Journal:  Otolaryngol Clin North Am        ISSN: 0030-6665            Impact factor:   3.346


  5 in total

Review 1.  Paranasal sinus cancer: caveats and controversies.

Authors:  John Waldron; Ian Witterick
Journal:  World J Surg       Date:  2003-07       Impact factor: 3.352

2.  Neoadjuvant chemoradiation in squamous cell carcinoma of the maxillary sinus: a 26-year experience.

Authors:  Matthias Kreppel; Sarah Danscheid; Martin Scheer; Jan Christoffer Lüers; Hans Theodor Eich; Joachim E Zöller; Orlando Guntinas-Lichius; Dirk Beutner
Journal:  Chemother Res Pract       Date:  2012-09-29

3.  Lymphoepithelial carcinoma in the maxillary sinus: a case report.

Authors:  Darouichi Mohammed; Alshammari Jaber; Monnier Philippe; Sandu Kishore
Journal:  J Med Case Rep       Date:  2012-12-11

4.  Intensity modulated radiotherapy (IMRT) in patients with carcinomas of the paranasal sinuses: clinical benefit for complex shaped target volumes.

Authors:  Stephanie E Combs; Stephan Konkel; Daniela Schulz-Ertner; Marc W Münter; Jürgen Debus; Peter E Huber; Christoph Thilmann
Journal:  Radiat Oncol       Date:  2006-07-21       Impact factor: 3.481

5.  Gamma Knife® radiosurgery for recurrent intracranial olfactory neuroblastoma (esthesioneuroblastoma): a case report.

Authors:  Eduard B Dinca; Matthias W Radatz; Jeremy Rowe; Andras A Kemeny
Journal:  J Med Case Rep       Date:  2012-08-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.